| Literature DB >> 34401724 |
Jamie A Green1,2, Patti L Ephraim3,4, Felicia Hill-Briggs5, Teri Browne6, Tara S Strigo7, Chelsie L Hauer8, Christina Yule9, Rebecca A Stametz8, Diane Littlewood10, Jane F Pendergast11, Sarah Peskoe11, Jennifer St Clair Russell7, Evan Norfolk1, Ion D Bucaloiu12, Shravan Kethireddy13, Daniel Davis14, Jeremy dePrisco8, Dave Malloy8, Sherri Fulmer15, Jennifer Martin16, Dori Schatell17, Navdeep Tangri18,19, Amanda Sees20, Cory Siegrist8, Jeffrey Breed8, Jonathan Billet8, Matthew Hackenberg8, Nrupen A Bhavsar7, L Ebony Boulware7.
Abstract
RATIONALE &Entities:
Keywords: Digital infrastructure; case management; chronic kidney disease; health information technology; shared decision making
Year: 2021 PMID: 34401724 PMCID: PMC8350843 DOI: 10.1016/j.xkme.2021.03.009
Source DB: PubMed Journal: Kidney Med ISSN: 2590-0595
Figure 1Integrated PREPARE NOW digital health system tools. Abbreviation: EHR, electronic health record.
Figure 2Chronic kidney disease (CKD) registry. Abbreviations: CM, case management; ER, emergency room; GFR, glomerular filtration rate.
Figure 3Patient values clarification tool.
Figure 4Kidney Care Transitions Specialist tracking tool. Abbreviations: BS, blood sugar; CKD, chronic kidney disease; CP, chest pain ; DM, diabetes mellitus; ENT, ear nose throat; HCC, hierarchical condition category; N/V, nausea/vomiting; SOB, short of breath.
CKD Stage and Risk for Kidney Failure at Entry Among Registry Participants
| CKD Stage | All Patients | Risk at Entry | ||||||
|---|---|---|---|---|---|---|---|---|
| Low | Moderate | High | ||||||
| No. (%) | Risk Score (median [IQR]) | No. (%) | Risk Score (median [IQR]) | No. (%) | Risk Score (median [IQR]) | No. (%) | Risk Score (median [IQR]) | |
| All stages | 1,032 (100%) | 0.02 [0.01-0.05] | 819 (79.4%) | 0.01 [0.01-0.03] | 69 (6.7%) | 0.07 [0.07-0.08] | 144 (13.9%) | 0.21 [0.13-0.37] |
| No. missing | — | 29 | — | 29 | — | 0 | — | 0 |
| Stage 3b | 583 (56.5%) | 0.01 [0.01-0.02] | 566 (97.1%) | 0.01 [0.01-0.02] | 11 (1.9%) | 0.08 [0.06-0.08] | 6 (1.0%) | 0.16 [0.13-0.25] |
| No. missing | -- | 1 | — | 1 | — | 0 | — | 0 |
| Stage 4 | 407 (39.4%) | 0.05 [0.03-0.10] | 249 (61.2%) | 0.03 [0.02-0.04] | 58 (14.2%) | 0.07 [0.07-0.08] | 100 (24.6%) | 0.18 [0.13-0.26] |
| No. missing | — | 24 | — | 24 | — | 0 | — | 0 |
| Stage 5 | 39 (3.8%) | 0.46 [0.30-0.68] | 1 (2.6%) | — | 0 (0.0%) | — | 38 (97.4%) | 0.46 [0.30-0.68] |
| No. missing | — | 1 | — | 1 | — | — | — | 0 |
| Not recorded at entry | 3 (0.3%) | — | 3 (100.0%) | — | 0 (0.0%) | — | 0 (0.0%) | — |
| No. missing | — | 3 | — | 3 | — | — | — | — |
Abbreviations: CKD, chronic kidney disease; IQR, interquartile range.
Characteristics of Enrolled Versus Not Enrolled in Kidney Case Management
| Characteristic | All Eligible Patients (N = 243) | Enrollment Status | |||
|---|---|---|---|---|---|
| Enrolled (n = 117) | Not Enrolled (n = 126) | ||||
| Age, y | 72 [59-81] | 71 [60-80] | 75 [59- 82] | 0.30 | |
| Female sex | 120 (49%) | 50 (43%) | 70 (56%) | 0.05 | |
| eGFR, mL/min/1.73 m2 | 22.9 [17.0-27.8] | 21.4 [16.6-25.7] | 24.1 [17.5-29.6] | 0.04 | |
| KFRE score | 0.13 [0.06-0.24] | 0.16 [0.10-0.28] | 0.08 [0.04-0.21] | <0.0001 | |
| Charlson Comorbidity Index score | 5 [4-7] | 6 [4-7] | 5 [4-7] | 0.71 | |
| Diabetes | 160 (66%) | 83 (71%) | 77 (61%) | 0.11 | |
| Cardiovascular disease | 144 (59%) | 65 (56%) | 79 (63%) | 0.26 | |
| Time on registry as of June 30, 2018 | 8 [8-9] | 8 [8-9] | 8 [7-8] | <0.001 | |
| 1-3 mo | 20 (8.2%) | 2 (1.7%) | 18 (14.3%) | ||
| 4-6 mo | 22 (9.1%) | 12 (10.3%) | 10 (7.9%) | <0.001 | |
| 7 9 mo | 169 (69.5%) | 79 (67.5%) | 90 (71.4%) | ||
| 10-12 mo | 32 (13.2%) | 24 (20.5%) | 8 (6.3%) | ||
| Years in nephrology | 3 [1-6] | 3 [1-6] | 4 [1-7] | 0.24 | |
Note: Values expressed as median [interquartile range] or number (percent).
Abbreviations: eGFR, estimated glomerular filtration rate; KFRE, Kidney Failure Risk Equation.
Chi-square tests for categorical measures and Kruskal-Wallis tests for continuous measures.
Characteristics of Receiving Versus Not Receiving Kidney Failure Treatment Modality Education
| Characteristic | All Enrolled Patients (N = 117) | Kidney Failure Treatment Modality Education | ||
|---|---|---|---|---|
| Received (n = 33) | Not Received (n = 84) | |||
| Age, y | 71 [60-80] | 71 [59-79] | 70 [61-80] | 0.73 |
| Female sex | 50 (43%) | 10 (30%) | 40 (48%) | 0.08 |
| eGFR, mL/min/1.73 m2 | 21.4 [16.6-25.7] | 22.3 [16.6-25.7] | 20.9 [16.6-25.5] | 0.81 |
| KFRE score | 0.16 [0.10-0.28] | 0.17 [0.08-0.29] | 0.16 [0.10-0.28] | 0.95 |
| Charlson Comorbidity Index score | 6 [4-7] | 5 [3-6] | 6 [4-8] | 0.01 |
| Diabetes | 83 (71%) | 22 (67%) | 61 (73%) | 0.52 |
| Cardiovascular disease | 65 (56%) | 65 (56%) | 79 (63%) | 0.26 |
| Time on registry as of June 30, 2018 | 8 [8-9] | 9 [9-10] | 8 [8,9] | 0.05 |
| 1-3 mo | 2 (1.7%) | 0 (0.0%) | 2 (2.4%) | |
| 4-6 mo | 12 (10.3%) | 4 (12.1%) | 8 (9.5%) | 0.29 |
| 7-9 mo | 79 (67.5%) | 19 (57.6%) | 60 (71.4%) | |
| 10-12 mo | 24 (20.5%) | 10 (30.3%) | 14 (16.7%) | |
| Time enrolled as of June 30, 2018 | 6 [4-9] | 8 [5-9] | 6 [3-8] | 0.02 |
| 1-3 mo | 25 (21.4%) | 3 (9.1%) | 22 (26.2%) | |
| 4-6 mo | 34 (29.1%) | 11 (33.3%) | 23 (27.4%) | 0.03 |
| 7-9 mo | 43 (36.8%) | 11 (33.3%) | 32 (38.1%) | |
| 10-12 mo | 15 (12.8%) | 8 (24.2%) | 7 (8.3%) | |
| Years in nephrology | 3 [1-6] | 3 [1-6] | 4 [1-7] | 0.69 |
Note: Values expressed as median [interquartile range] or number (percent).
Abbreviations: eGFR, estimated glomerular filtration rate; KFRE, Kidney Failure Risk Equation.
Chi-square tests for categorical measures and Kruskal-Wallis tests for continuous measures.
Kidney Transitions Specialist Feedback on Use of Tools
| Tool | Theme | Quotes |
|---|---|---|
| CKD registry | Patient identification and risk stratification | “The CKD registry is a great tool in identifying which patients are at highest level of acuity according to the numbers. It is helpful having all the information in one place as far as function, appointments and identifying information.” |
| Values tool | Alignment of values | “The Values tool is helpful in seeing what is important to the patient and then you can refer to it as you go through the Kidney Options class. I think it is helpful for the patient to see what is important to him in writing and having to stop and think about it.” |
| Values tool | Digital literacy | “The iPads are not always user friendly, especially to older population. Paper copy seems to work better and is easily transferred to chart.” |
| Navigation and tracking tool | Efficiency | “[the navigation and tracking tool] helps to cut [down] on documentation time to spend more conversation time with patients.” |
| Navigation and tracking tool | Duplicate data entry | “Would be nicer if the referrals and completed appts (eg, palliative, transplant, vascular) placed would flow automatically [from EPIC] into the tracker tool just like the [Kidney] Options completed classes.” |
Abbreviation: CKD, chronic kidney disease.
Alternatives to PREPARE NOW Digital Tools
| Tool | Alternatives |
|---|---|
| CKD registry with risk prediction | Kidney Failure Risk Equation is freely available online ( |
| Patient values tool | Standard EHR questionnaire functionality can be used Several online decision aids are freely available |
| Navigation and tracking tool | Similar tracking elements can be embedded within other case management platforms or provider EHR templates |
| Treatment preferences broadcast | Treatment preferences available in Intelligent Medical Objects database Renal replacement therapy goals panel (National Kidney Disease Education Program) – LOINC Code 85597-3 Epic CKD Checklist SmartForm available |
Abbreviations: CKD, chronic kidney disease; EHR, electronic health record.